Cite
Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma.
MLA
Fei, Zhaodong, et al. “Effectiveness and Cost-Effectiveness Analysis of Nimotuzumab for the Radiotherapy of Locoregionally Advanced Nasopharyngeal Carcinoma.” Radiation Oncology, vol. 15, no. 1, Oct. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13014-020-01674-5.
APA
Fei, Z., Xu, T., Li, M., Chen, T., Li, L., Qiu, X., & Chen, C. (2020). Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma. Radiation Oncology, 15(1), 1–9. https://doi.org/10.1186/s13014-020-01674-5
Chicago
Fei, Zhaodong, Ting Xu, Mengying Li, Taojun Chen, Li Li, Xiufang Qiu, and Chuanben Chen. 2020. “Effectiveness and Cost-Effectiveness Analysis of Nimotuzumab for the Radiotherapy of Locoregionally Advanced Nasopharyngeal Carcinoma.” Radiation Oncology 15 (1): 1–9. doi:10.1186/s13014-020-01674-5.